r-limonene
Small moleculeexperimental
Clinical trial activity
6 trials · 10 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2007 (NCT01459172)
Timeline
Indications
Mechanism of action
LHFPL4 unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05525260 | Phase 2 | Sep 30, 2022 | Jiao Tong University |
| NCT05078723 | N/A | Oct 30, 2021 | Stanford University |
| NCT04853082 | Early Phase 1 (Phase 1) | Feb 22, 2021 | Jiao Tong University, Shanghai Shen Kang Hospital, Shanghai University |
| NCT03609853 | Phase 1 | Sep 15, 2018 | Johns Hopkins University, National Institute on Drug Abuse (NIDA) |
| NCT03313232 | N/A | Oct 10, 2017 | University of Copenhagen, University of Gothenburg |
| NCT01459172 | Phase 1 | Oct 31, 2007 | Department of Defense, University of Arizona |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (10)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiao Tong University | Academic/Hospital | 2 | 2 | 2 | 2021 |
| Department of Defense | Government | 1 | 0 | 1 | 2007 |
| Johns Hopkins University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| National Institute on Drug Abuse (NIDA) | Government | 1 | 0 | 1 | 2018 |
| Shanghai Shen Kang Hospital | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Shanghai University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of Arizona | Academic/Hospital | 1 | 1 | 1 | 2007 |
| University of Copenhagen | Academic/Hospital | 1 | 1 | 1 | 2017 |
| University of Gothenburg | Academic/Hospital | 1 | 0 | 1 | 2017 |
10 organizations
Page 1 / 1